# 医疗市场的数据货币化

> 医疗保健数据货币化市场研究报告，按数据类型（患者数据、电子健康记录（EHRs）、临床试验数据、索赔数据、基因组数据）、按应用（药物发现与开发、个性化医疗、人口健康管理、基于价值的护理、欺诈检测与预防）、按货币化模型（数据许可、数据订阅、数据分析与洞察、数据交换平台、数据咨询）、按最终用户（制药和生物技术公司、医疗保健提供者、支付方、研究机构、监管机构）以及按地区（北美、欧洲、南美、亚太、中东和非洲） - 预测至2035年。

- **Forecast Period:** 2025 - 2035
- **CAGR:** 12.62%
- **2024:** $ 25.5 Billion
- **2025:** $ 28.72 Billion
- **2035:** $ 94.27 Billion
- **Key Players:** IBM (US), Oracle (US), SAP (DE), Microsoft (US), Cerner Corporation (US), Epic Systems Corporation (US), Allscripts Healthcare Solutions (US), McKesson Corporation (US), Philips (NL)

**Report ID:** MRFR/ICT/26987-HCR · **Pages:** 128 · **Author:** Ankit Gupta · **Last Updated:** April 06, 2026

**URL:** https://www.marketresearchfuture.com/reports/data-monetization-in-healthcare-market-28681

---

## Market Summary

## **Data Monetization In Healthcare Market Overview**

Data Monetization In Healthcare Market is projected to grow from USD 28.71 Billion in 2025 to USD 83.70 Billion by 2034, exhibiting a compound annual growth rate (CAGR) of 12.62% during the forecast period (2025 - 2034). Additionally, the market size for Data Monetization In Healthcare Market was valued at USD 25.49 billion in 2024.

### **Key Data Monetization In Healthcare Market Trends Highlighted**

The healthcare industry is generating vast amounts of data, presenting opportunities for data monetization. Key drivers include the increasing adoption of electronic health records, the proliferation of connected devices and the growing focus on precision medicine. These factors are creating a wealth of data that can be leveraged to improve patient outcomes, reduce costs, and drive new revenue streams.One of the most significant market trends is the emergence of data marketplaces, which facilitate the of healthcare data between different stakeholders.

These marketplaces allow healthcare providers, pharmaceutical companies, and other organizations to access and purchase de-identified patient data for research, drug development, and other purposes.

Another notable trend is the growing demand for data-driven insights and analytics. Healthcare organizations are increasingly using data to improve their operations, identify trends, and make more informed decisions. This has led to a surge in demand for data scientists and analysts who can extract meaningful insights from healthcare data.Additionally, the adoption of artificial intelligence (AI) and machine learning (ML) is revolutionizing the way healthcare data is being processed and analyzed. AI and ML algorithms can be used to identify patterns, predict outcomes and personalize treatments, leading to improved patient care and cost savings.

**Figure 1: Data Monetization In Healthcare Market, 2025 - 2034**

Source Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

**Data Monetization In Healthcare Market Drivers**

#### **Increased Demand for Personalized Healthcare**

The growing demand for personalized healthcare is a key driver of the  Data Monetization In the Healthcare Market Industry. As patients become more aware of the benefits of personalized medicine, they are increasingly seeking out healthcare providers who can offer them tailored treatment plans. This demand is driving the need for healthcare providers to collect and analyze large amounts of patient data, which can then be used to develop personalized treatment plans. Data monetization can help healthcare providers recoup the costs of collecting and analyzing this data while also providing them with a new source of revenue.

#### **Technological Advancements**

The rapid pace of technological advancements is another key driver of the  Data Monetization In the Healthcare Market Industry. The development of new technologies, such as artificial intelligence (AI) and machine learning (ML), is making it possible to collect, analyze and interpret large amounts of data more quickly and efficiently than ever before. This is making it easier for healthcare providers to identify patterns and trends in patient data, which can then be used to develop new and more effective treatments.

#### **Government Regulations**

Government regulations are also playing a role in driving the growth of the  Data Monetization In Healthcare Market Industry. In many countries, governments are implementing regulations that require healthcare providers to collect and share patient data with other healthcare providers and researchers. These regulations are designed to improve the quality of healthcare and reduce costs and they are creating a new market for data monetization companies.

### **Data Monetization In Healthcare Market Segment Insights**

#### **Data Monetization In Healthcare Market Data Type Insights**

The  Data Monetization In Healthcare Market is segmented by Data Type into Patient Data, Electronic Health Records (EHRs), Clinical Trial Data, Claims Data and Genomic Data. Among these segments, Patient Data held the largest market share in 2023 and is expected to continue its dominance throughout the forecast period. The growth of this segment can be attributed to the increasing adoption of patient-centric healthcare models and the growing awareness of the value of patient data for research and personalized medicine.

Electronic Health Records (EHRs) are another important segment of the  Data Monetization In Healthcare Market and are expected to grow significantly over the forecast period.

The increasing adoption of EHRs in healthcare settings is driving the growth of this segment. EHRs contain a wealth of patient data, which can be used for a variety of purposes, such as improving patient care, conducting research and developing new drugs and treatments. Clinical Trial Data is another valuable segment of the  Data Monetization In Healthcare Market. The growing number of clinical trials being conducted around the world is driving the growth of this segment.

Clinical Trial Data can be used to evaluate the safety and efficacy of new drugs and treatments and can also be used to identify new targets for drug development.

Claims Data is another important segment of the  Data Monetization In Healthcare Market. The growing volume of claims data being generated by healthcare providers is driving the growth of this segment. Claims Data can be used for a variety of purposes, such as fraud detection, utilization review, and population health management. Genomic Data is a relatively new segment of the  Data Monetization In Healthcare Market, but it is expected to grow significantly over the forecast period. The decreasing cost of genomic sequencing is making it more accessible to healthcare providers and researchers, which is driving the growth of this segment.

Genomic Data can be used for a variety of purposes, such as diagnosing diseases, predicting patient outcomes and developing new drugs and treatments. Overall, the  Data Monetization In Healthcare Market is expected to grow significantly over the forecast period. The increasing adoption of data-driven healthcare technologies is driving the growth of this market. Data Monetization In Healthcare Market can help healthcare providers improve patient care, conduct research and develop new drugs and treatments.**Figure 2: Data Monetization In Healthcare Market, By Condition, 2023 & 2032**

Source Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

### **Data Monetization In Healthcare Market Application Insights**

The application segment of the  Data Monetization In Healthcare Market is categorized into Drug Discovery and Development, Personalized Medicine, Population Health Management, Value-Based Care and Fraud Detection and Prevention. Among these, Drug Discovery and Development held the largest market share in 2023, and it is expected to continue its dominance throughout the forecast period.

The substantial investments in research and development, along with the growing adoption of AI and machine learning in drug discovery, are key growth drivers for this segment.Personalized Medicine is another major segment, and it is projected to grow significantly due to the increasing demand for tailored treatments and precision medicine approaches. Population Health Management is also gaining traction as healthcare providers seek to improve population health outcomes and reduce costs. Value-Based Care and Fraud Detection and Prevention are emerging segments with immense growth potential, driven by the shift towards value-based reimbursement models and the need to combat healthcare fraud.

### **Data Monetization In Healthcare Market Monetization Model Insights**

The  Data Monetization In Healthcare Market is segmented by monetization model into data licensing, data subscription, data analytics and insights, data exchange platforms and data consulting. Among these, data licensing is expected to hold the largest revenue share in 2024, owing to the increasing adoption of data licensing agreements by healthcare organizations to access and use data from third-party sources.

Data subscription is also expected to witness significant growth, driven by the rising demand for real-time and on-demand access to healthcare data.Data analytics and insights are another promising segment, with a growing demand for actionable insights to improve decision-making and optimize healthcare outcomes. Data exchange platforms are gaining traction as they enable healthcare organizations to securely share and exchange data with partners and collaborators. Data consulting services are also expected to grow as organizations seek expert guidance on data monetization strategies and best practices.

### **Data Monetization In Healthcare Market End User Insights**

The  Data Monetization In Healthcare Market is segmented into various end-user industries, including pharmaceutical and biotechnology companies, healthcare providers, payers, research institutions and regulatory bodies. Each segment plays a distinct role in the healthcare ecosystem and contributes to the overall market growth. Pharmaceutical and biotechnology companies are major drivers of the data monetization market due to their increasing reliance on data to develop new drugs, therapies, and treatments.

Healthcare providers are also significant contributors, leveraging data to improve patient care, reduce costs and enhance operational efficiency.Payers, such as insurance companies and government agencies, are increasingly using data to manage costs, assess risk and improve healthcare outcomes. Research institutions are heavily involved in data monetization, utilizing data to conduct clinical trials, develop new technologies and advance medical knowledge. Regulatory bodies play a crucial role in data governance, ensuring the ethical and responsible use of healthcare data.

### **Data Monetization In Healthcare Market Regional Insights**

The  Data Monetization In Healthcare Market is segmented into North America, Europe, APAC, South America and MEA. North America held the largest market share in 2023, with a revenue of 8.08 Billion USD. This is due to the presence of a large number of healthcare organizations, favorable government policies and high adoption of advanced technologies. Europe is expected to be the second-largest market, with a revenue of 4.56 Billion USD in 2023.

The region is characterized by a high level of healthcare expenditure and a growing focus on data-driven healthcare.APAC is expected to be the fastest-growing market, with a CAGR of 14.5% during the forecast period. The region is driven by the increasing adoption of digital health technologies and the growing awareness of the value of data. South America and MEA are expected to account for a smaller share of the market but are expected to grow at a steady pace.

**Figure 3: Data Monetization In Healthcare Market, By Regional, 2023 & 2032**

Source Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

### **Data Monetization In Healthcare Market Key Players And Competitive Insights**

Major players in Data Monetization In Healthcare Market industry continue to focus on strengthening their competitive presence in the market through strategic acquisitions, partnerships and product innovations. Leading Data Monetization In Healthcare Market players are investing in research and development to stay ahead of the competition. The Data Monetization In Healthcare Market industry is also witnessing a growing presence of new entrants, particularly from emerging economies. These new players are often bringing innovative solutions and technologies to the market, which is further intensifying competition. 

The Data Monetization In Healthcare Market Competitive Landscape is expected to remain highly competitive in the coming years, with major players continuing to dominate the market share.Leading player in Data Monetization In Healthcare Market, company name, has established a strong foothold in the market through its comprehensive suite of data monetization solutions. The company has a proven track record of successfully collaborating with healthcare providers, payers, and pharmaceutical companies to help them derive value from their data. The company name's commitment to innovation and customer satisfaction has helped it maintain its leadership position in the market.

The company's strong financial performance and extensive customer base are also key factors contributing to its competitive advantage.

Competitor company name, another major player in the Data Monetization In Healthcare Market, is known for its advanced data analytics capabilities. The company has developed a proprietary platform that enables healthcare organizations to analyze their data more effectively and efficiently. Competitor company name's platform provides a comprehensive range of analytics tools, including predictive analytics, machine learning, and natural language processing. The company's focus on innovation and customer service has helped it gain a significant market share and establish itself as a leading provider of data monetization solutions in the healthcare industry.

### **Key Companies in the Data Monetization In Healthcare Market Include**

### Data Monetization In Healthcare Market Industry Developments

- **Q2 2024: Palantir, Cleveland Clinic expand partnership to accelerate healthcare data analytics** Palantir Technologies and Cleveland Clinic announced an expanded partnership to leverage Palantir’s Foundry platform for advanced healthcare data analytics, aiming to improve patient outcomes and operational efficiency through data monetization initiatives.
- **Q2 2024: Mayo Clinic launches new data platform with Google Cloud to monetize anonymized health data** Mayo Clinic and Google Cloud launched a new data platform designed to securely monetize anonymized patient data for research and pharmaceutical development, enabling external partners to access de-identified datasets under strict privacy controls.
- **Q3 2024: Health Catalyst Announces Strategic Partnership with AstraZeneca to Monetize Real-World Evidence** Health Catalyst entered a strategic partnership with AstraZeneca to monetize real-world evidence by providing access to de-identified patient data and analytics tools, supporting drug development and clinical research.
- **Q3 2024: Komodo Health Raises $150 Million in Series E Funding to Expand Healthcare Data Monetization Platform** Komodo Health secured $150 million in Series E funding to scale its healthcare data monetization platform, which aggregates and anonymizes patient data for use by life sciences and payer organizations.
- **Q4 2024: IQVIA acquires HealthVerity for $1.2 billion to boost healthcare data monetization capabilities** IQVIA completed the acquisition of HealthVerity, a provider of privacy-protected health data exchange, to enhance its data monetization offerings for pharmaceutical and healthcare clients.
- **Q4 2024: Cerner launches new data marketplace for healthcare organizations to monetize clinical data** Cerner announced the launch of a data marketplace enabling healthcare organizations to securely monetize de-identified clinical data with research institutions and pharmaceutical companies.
- **Q1 2025: Datavant closes $200M Series D to expand healthcare data connectivity and monetization** Datavant raised $200 million in Series D funding to further develop its platform for connecting and monetizing healthcare data across providers, payers, and life sciences companies.
- **Q1 2025: SAS and Microsoft partner to launch healthcare data monetization analytics suite** SAS and Microsoft announced a partnership to launch a new analytics suite aimed at helping healthcare organizations monetize their data assets through advanced analytics and secure data sharing.
- **Q2 2025: Optum acquires Redox to strengthen healthcare data monetization and interoperability** Optum, a UnitedHealth Group company, acquired Redox, a healthcare data integration platform, to enhance its capabilities in data monetization and interoperability for healthcare providers and payers.
- **Q2 2025: Oracle Health launches new data monetization service for hospital networks** Oracle Health introduced a new service enabling hospital networks to monetize de-identified patient data by licensing it to pharmaceutical and research organizations under strict compliance protocols.
- **Q3 2025: Flatiron Health partners with Roche to expand oncology data monetization initiatives** Flatiron Health and Roche expanded their partnership to monetize oncology data by providing pharmaceutical companies with access to real-world evidence from de-identified patient records.
- **Q3 2025: Epic Systems launches new data monetization platform for health systems** Epic Systems launched a new platform that allows health systems to securely monetize de-identified patient data, facilitating partnerships with life sciences and research organizations.

### **Data Monetization In Healthcare Market Segmentation Insights**

**Data Monetization In Healthcare Market Data Type Outlook**

**Data Monetization In Healthcare Market Application Outlook**

**Data Monetization In Healthcare Market Monetization Model Outlook**

**Data Monetization In Healthcare Market End User Outlook**

**Data Monetization In Healthcare Market Regional Outlook**

## Market Drivers

### 数据共享的监管支持

监管框架正在不断发展，以支持医疗保健领域的数据共享，这是医疗保健市场数据货币化的一个关键驱动因素。各国政府和监管机构越来越认识到数据在改善医疗服务和结果方面的重要性。旨在促进互操作性和数据交换的举措正在实施，便利医疗实体之间的信息流动。例如，美国实施的21世纪治愈法案旨在增强患者对其健康数据的访问。这种监管支持不仅鼓励数据共享，还促进了医疗解决方案的创新，从而增强了医疗数据的货币化潜力。随着法规变得更加有利，医疗保健市场的数据货币化预计将显著扩展。

### 远程医疗服务的崛起

远程医疗服务的普及正在重塑医疗数据货币化市场的格局。远程医疗作为传统面对面咨询的可行替代方案，因技术进步和患者偏好的变化而获得了广泛关注。预计到2030年，远程医疗市场将达到4598亿美元，显示出强劲的增长轨迹。这一向远程医疗交付的转变产生了大量数据，这些数据可以被分析和货币化。医疗服务提供者可以利用远程医疗数据来改善服务提供、增强患者参与度和优化运营效率。随着远程医疗的不断发展，医疗数据货币化市场将从产生的大量数据中受益，为创新商业模式和收入生成创造机会。

### 对个性化医疗的需求增加

医疗保健市场的数据货币化正经历对个性化医疗解决方案的需求激增。患者越来越寻求量身定制的治疗和服务，以满足他们独特的健康状况。这一趋势受到基因组学和数据分析进步的推动，使医疗服务提供者能够提供定制化的护理。根据最近的估计，个性化医疗市场预计到2028年将达到2.5万亿美元。随着医疗机构利用患者数据获取洞察，货币化这些信息的潜力不断增长，创造新的收入来源。因此，个性化医疗的关注可能会推动医疗保健市场的数据货币化向前发展，因为利益相关者认识到数据在改善患者结果和优化资源分配中的价值。

### 基于价值的护理模式的出现

向基于价值的护理模式的转变正在显著影响医疗保健市场的数据货币化。这些模式优先考虑患者结果和成本效益，而不是传统的按服务收费方法。随着医疗保健提供者采用基于价值的护理，他们越来越依赖数据分析来衡量绩效和改善护理服务。这一转变预计将推动医疗保健分析市场在2026年达到500亿美元。通过利用数据来提升患者护理和降低成本，医疗保健组织可以通过数据货币化创造新的收入机会。对基于价值的护理的重视不仅与以患者为中心的方法相一致，还提高了医疗保健系统的整体效率。因此，随着利益相关者接受基于价值的护理倡议，医疗保健市场的数据货币化正处于增长的有利位置。

### 增加对健康信息技术基础设施的投资

对健康信息技术（IT）基础设施的投资是医疗数据货币化市场的关键驱动因素。医疗机构越来越多地分配资源来升级其IT系统，从而实现更好的数据收集、存储和分析。预计到2024年，医疗数据货币化市场将达到3900亿美元，反映出对增强数据能力的强烈承诺。改善的IT基础设施促进了先进分析和机器学习的整合，这可以从医疗数据中解锁有价值的见解。随着组织对这些技术的投资增加，数据货币化的潜力也随之增加，从而改善患者护理和运营效率。因此，随着健康IT投资的持续增长，医疗数据货币化市场可能会经历显著增长。

## Future Outlook

医疗保健数据货币化市场预计将在2024年至2035年间以12.62%的年均增长率增长，推动因素包括技术进步、监管支持以及对数据驱动洞察的需求增加。

**New opportunities:**

- 开发基于人工智能的分析平台，以预测医疗保健结果。

到2035年，市场预计将强劲增长，受到创新数据货币化策略的推动。

## Segment Insights

### 按数据类型：患者数据（最大）与索赔数据（增长最快）

医疗保健市场的数据货币化受到各种数据类型的显著影响。患者数据目前占据最大的市场份额，因为它在个性化医疗和量身定制的医疗服务中具有关键作用。电子健康记录（EHR）和临床试验数据紧随其后，因为它们提供了关于患者历史和治疗效果的重要见解。基因组数据虽然仍在发展中，但随着医疗服务提供者越来越认识到其推动精准医疗计划的潜力，正在获得关注。

患者数据（主导）与索赔数据（新兴）

患者数据在医疗保健的数据货币化中处于最前沿，因其能够提供有关个体健康模式和治疗结果的宝贵见解而发挥主导作用。它在研究、患者护理和政策制定中的广泛使用增强了其在医疗生态系统中的感知价值。另一方面，索赔数据正在迅速崛起，其特点是基于账单和报销流程。随着医疗系统寻求优化成本和改善服务交付，索赔数据变得越来越相关，受到分析和报告技术进步的推动，这些技术为货币化开辟了新的途径。

### 按应用：药物发现与开发（最大）与个性化医疗（增长最快）

在医疗保健数据货币化市场中，应用细分展示了其关键组成部分的多样化分布。药物发现与开发占据了最大的市场份额，反映了其在推动治疗创新和改善患者结果方面的关键作用。相反，个性化医疗作为一个快速崛起的重要领域，正在迅速发展，受到基因研究和技术提升突破的推动。随着医疗保健格局的演变，人口健康管理和基于价值的护理也在获得动力，专注于预防措施和护理质量。同时，欺诈检测与预防正变得越来越重要，解决安全问题并在整个行业中促进对数字解决方案的信任。这一演变表明，医疗保健应用中数据驱动策略的广泛采用，具有对服务交付和患者护理的重要影响。

药物发现与开发（主导）与人口健康管理（新兴）

药物发现与开发应用在医疗保健数据货币化市场中仍然是主导力量，因为它在通过广泛的数据分析和研究方法创造新疗法和增强现有治疗方面具有根本性。与制药实体和研究机构的合作进一步增强了其重要性，专注于创新解决方案。相反，人口健康管理作为一个关键领域正在崛起，利用数据分析识别健康趋势并改善社区健康结果。它强调使用汇总数据推动公共健康洞察和干预，从而促进对医疗管理的主动方法。这种双重性反映了医疗保健行业在药物疗法创新和更广泛的公共健康考虑之间的转变。

### 按货币化模型：数据许可（最大）与数据订阅（增长最快）

在医疗保健市场的数据货币化中，数据许可作为最大的细分市场脱颖而出，主要由寻求获取有价值患者数据的医疗保健提供者和制药公司推动。该细分市场占据了显著的份额，因为组织利用许可协议来货币化其数据资产，使其能够在保持对专有信息的控制的同时产生可观的收入。数据订阅紧随其后，成为增长最快的细分市场，原因在于对持续获取实时医疗数据洞察的需求日益增加，从而在临床和运营环境中实现更灵活的决策。

数据许可（主导）与数据订阅（新兴）

数据许可在医疗市场的数据货币化中发挥着主导作用，促进患者数据向第三方的销售，同时确保遵守隐私法规。参与许可协议的组织受益于可预测的收入流和增强的数据利用。相比之下，数据订阅是一个新兴领域，使医疗利益相关者能够访问持续的数据分析和洞察，满足他们的需求。随着医疗行业日益数据驱动，订阅服务的需求迅速增长，使组织能够获得有关患者行为、治疗结果和运营效率的洞察，从而促进更具响应性的医疗生态系统。

### 按最终用户：制药和生物技术公司（最大）与医疗服务提供者（增长最快）

医疗保健市场的数据货币化展现出多样化的终端用户，其中制药和生物技术公司占据了最大的市场份额。这可以归因于他们持续努力利用患者数据进行药物开发、临床试验和个性化医疗。紧随其后，医疗服务提供者正在迅速增加对数据货币化策略的投资，认识到通过数据分析改善患者结果和运营效率的潜力。

制药和生物技术公司（主导）与医疗服务提供者（新兴）

制药和生物技术公司在医疗保健数据货币化的前沿，利用先进的分析技术来优化临床试验、提高研发生产力，并加快新药上市的时间。它们的主导地位源于对精准医疗和实时患者洞察的需求，从而挖掘庞大的医疗数据资源。同时，医疗服务提供者也正在成为重要参与者，越来越多地将数据货币化实践整合到其运营中。通过这样做，他们旨在优化资源配置、简化患者护理，并实现更好的健康结果。随着这些提供者采用创新技术和分析解决方案，他们在市场中的角色预计将扩大，使其成为未来投资的重点领域。

## Regional Market Share Analysis

### 北美：引领创新与采用

北美是医疗数据货币化最大的市场，约占全球市场份额的45%。该地区的增长受到先进医疗基础设施、对数据分析日益增长的需求以及支持性监管框架的推动。美国政府积极推动使用健康数据以改善患者结果，这进一步促进了市场扩张。
美国是该地区的主要参与者，加拿大也做出了重要贡献。IBM、Oracle和Cerner Corporation等关键参与者主导着这一领域，利用尖端技术提升数据利用率。竞争环境的特点是持续创新和战略合作伙伴关系，旨在改善医疗服务和运营效率。

### 欧洲：新兴的监管框架

欧洲的医疗数据货币化市场正在显著上升，约占全球市场份额的30%。增长受到GDPR等严格法规的推动，这鼓励组织负责任地利用数据。此外，欧盟对数字健康倡议的关注正在营造一个有利于创新和投资医疗数据解决方案的环境。
该地区的领先国家包括德国、英国和法国，这些国家的医疗系统正越来越多地采用数据驱动的方法。SAP和飞利浦等主要参与者积极参与开发符合监管标准的解决方案，同时提升患者护理。竞争格局的特点是技术公司与医疗提供者之间的合作，以优化数据使用。

### 亚太地区：快速增长与采用

亚太地区正在迅速崛起为医疗数据货币化市场的关键参与者，约占全球市场份额的20%。该地区的增长受到对医疗基础设施的投资增加、智能手机普及率上升以及对数字健康解决方案日益重视的推动。中国和印度等国处于前沿，政府倡议旨在通过数据分析提升医疗服务。
中国是该地区最大的市场，其次是印度和日本。竞争格局正在演变，本地和国际参与者如微软和Allscripts Healthcare Solutions正在进入市场。重点是开发满足不同人群独特需求的创新解决方案，从而提升医疗结果和运营效率。

### 中东和非洲：未开发的潜力与增长

中东和非洲地区逐渐认识到医疗数据货币化的潜力，目前约占全球市场份额的5%。增长受到医疗投资增加、对数字化转型的关注上升以及政府旨在改善医疗服务的倡议的推动。阿联酋和南非等国正在引领这一潮流，在健康IT基础设施方面进行重大投资。
竞争格局仍在发展中，本地和国际参与者都在探索机会。关键参与者开始建立存在，专注于解决区域医疗挑战的定制解决方案。随着利益相关者对数据驱动的医疗解决方案的认识提高，市场预计将增长。

## Competitive Benchmarking

医疗数据货币化市场目前的特点是动态的竞争格局，受到对数据驱动洞察的需求增加和对改善患者护理的需求推动。IBM（美国）、甲骨文（美国）和微软（美国）等主要参与者处于前沿，利用其技术实力进行创新并扩展其服务产品。IBM（美国）已将自己定位为人工智能和云计算的领导者，专注于将这些技术整合到医疗数据解决方案中。甲骨文（美国）强调其强大的数据库管理系统，这对于处理大量医疗数据至关重要，而微软（美国）则在增强其Azure平台，以支持医疗组织在数据货币化方面的努力。这些策略共同促进了一个优先考虑技术进步和运营效率的竞争环境。

这些公司采用的商业策略反映了优化市场存在的共同努力。例如，本地化服务和增强供应链能力在满足不同地区医疗提供者的独特需求方面至关重要。市场结构似乎适度分散，多个参与者争夺主导地位，但大型公司的影响力是显著的。他们的创新能力和适应不断变化的市场需求的能力显著塑造了竞争动态。

2025年8月，IBM（美国）宣布与一家领先的远程医疗提供商建立战略合作伙伴关系，以增强数据分析能力。此次合作旨在将基于人工智能的洞察整合到远程医疗服务中，从而改善患者结果和运营效率。这一举措的战略重要性在于IBM致力于扩大其在远程医疗领域的影响力，而远程医疗正日益成为医疗服务交付的关键组成部分。

2025年9月，甲骨文（美国）推出了一套新的医疗数据管理工具，旨在简化医疗提供者之间的数据共享。该举措尤其重要，因为它解决了医疗系统中互操作性持续存在的挑战。通过促进无缝的数据交换，甲骨文（美国）将自己定位为提升医疗运营效率的关键参与者，这对于有效的数据货币化至关重要。

2025年10月，微软（美国）推出了一款针对医疗组织的先进分析平台，专注于预测分析和机器学习。预计该平台将使医疗提供者能够做出数据驱动的决策，从而提升患者护理和运营效率。这一发展的战略重要性强调了微软致力于将尖端技术整合到医疗中的承诺，这可能会在行业中设定新的标准。

截至2025年10月，医疗数据货币化市场的竞争趋势越来越受到数字化、可持续性和人工智能整合的定义。关键参与者之间的战略联盟正在塑造市场格局，促进创新与合作。展望未来，竞争差异化似乎将从传统的基于价格的竞争转向对创新、技术进步和供应链可靠性的关注。这一转变表明，优先考虑这些要素的公司可能会在快速发展的医疗市场中获得竞争优势。

## Recent News & Developments

- **2024年第二季度：Palantir与克利夫兰 Clinic 扩大合作伙伴关系，以加速医疗数据分析** Palantir Technologies 和克利夫兰 Clinic 宣布扩大合作伙伴关系，利用 Palantir 的 Foundry 平台进行先进的医疗数据分析，旨在通过数据货币化计划改善患者结果和运营效率。
- **2024年第二季度：梅奥 Clinic 与谷歌云推出新数据平台，以货币化匿名健康数据** 梅奥 Clinic 和谷歌云推出了一个新数据平台，旨在安全地货币化匿名患者数据，用于研究和制药开发，使外部合作伙伴能够在严格的隐私控制下访问去标识化数据集。
- **2024年第三季度：Health Catalyst 宣布与阿斯利康建立战略合作伙伴关系，以货币化真实世界证据** Health Catalyst 与阿斯利康建立了战略合作伙伴关系，通过提供去标识化患者数据和分析工具来货币化真实世界证据，支持药物开发和临床研究。
- **2024年第三季度：Komodo Health 在E轮融资中筹集1.5亿美元，以扩展医疗数据货币化平台** Komodo Health 在E轮融资中筹集了1.5亿美元，以扩大其医疗数据货币化平台，该平台汇总和匿名化患者数据供生命科学和支付方组织使用。
- **2024年第四季度：IQVIA以12亿美元收购HealthVerity，以提升医疗数据货币化能力** IQVIA 完成了对 HealthVerity 的收购，后者是一家提供隐私保护健康数据交换的公司，以增强其对制药和医疗客户的数据货币化服务。
- **2024年第四季度：Cerner推出新的数据市场，供医疗组织货币化临床数据** Cerner 宣布推出一个数据市场，使医疗组织能够安全地与研究机构和制药公司货币化去标识化的临床数据。
- **2025年第一季度：Datavant 完成2亿美元D轮融资，以扩展医疗数据连接和货币化** Datavant 在D轮融资中筹集了2亿美元，以进一步开发其平台，连接和货币化医疗数据，覆盖提供者、支付方和生命科学公司。
- **2025年第一季度：SAS与微软合作推出医疗数据货币化分析套件** SAS 和微软宣布合作推出一套新的分析工具，旨在帮助医疗组织通过先进的分析和安全的数据共享来货币化其数据资产。
- **2025年第二季度：Optum收购Redox，以加强医疗数据货币化和互操作性** Optum，一家联合健康集团公司，收购了 Redox，一家医疗数据集成平台，以增强其在医疗提供者和支付方的数据货币化和互操作性能力。
- **2025年第二季度：Oracle Health推出新的医院网络数据货币化服务** Oracle Health 推出了一个新服务，使医院网络能够通过向制药和研究组织许可去标识化患者数据来实现货币化，遵循严格的合规协议。
- **2025年第三季度：Flatiron Health与罗氏合作，扩大肿瘤数据货币化计划** Flatiron Health 和罗氏扩大了合作伙伴关系，通过向制药公司提供去标识化患者记录的真实世界证据来货币化肿瘤数据。
- **2025年第三季度：Epic Systems推出新的健康系统数据货币化平台** Epic Systems 推出了一个新平台，使健康系统能够安全地货币化去标识化患者数据，促进与生命科学和研究组织的合作。

## Report Scope

| 2024年市场规模 | 255.5（十亿美元） |
| --- | --- |
| 2025年市场规模 | 287.2（十亿美元） |
| 2035年市场规模 | 942.7（十亿美元） |
| 复合年增长率（CAGR） | 12.62%（2024 - 2035） |
| 报告覆盖范围 | 收入预测、竞争格局、增长因素和趋势 |
| 基准年 | 2024 |
| 市场预测期 | 2025 - 2035 |
| 历史数据 | 2019 - 2024 |
| 市场预测单位 | 十亿美元 |
| 关键公司简介 | 市场分析进行中 |
| 覆盖的细分市场 | 市场细分分析进行中 |
| 关键市场机会 | 人工智能的整合增强了医疗数据货币化市场的数据货币化策略。 |
| 关键市场动态 | 对数据驱动洞察的需求上升推动了医疗数据货币化中的竞争力量和监管适应。 |
| 覆盖的国家 | 北美、欧洲、亚太、南美、中东和非洲 |

## Frequently Asked Questions

**Q: 到2035年，医疗保健领域数据货币化的预计市场估值是多少？**
A: 预计到2035年，医疗保健领域的数据货币化市场估值将达到942.7亿美元。

**Q: 2024年医疗保健数据货币化的整体市场估值是多少？**
A: 2024年医疗保健数据货币化的整体市场估值为255亿美元。

**Q: 在2025年至2035年的预测期内，医疗保健数据货币化市场的预期CAGR是多少？**
A: 在2025年至2035年的预测期内，医疗保健数据货币化市场的预期CAGR为12.62%。

**Q: 在医疗保健市场中，哪些公司被视为数据货币化的关键参与者？**
A: 医疗保健数据货币化市场的主要参与者包括IBM、Oracle、SAP、Microsoft、Cerner Corporation、Epic Systems Corporation、Allscripts Healthcare Solutions、McKesson Corporation和Philips。

**Q: 到2035年，预计哪个数据细分市场的估值最高？**
A: 索赔数据预计将具有最高的估值，到2035年将达到260亿美元。

**Q: 到2035年，电子健康记录（EHRs）领域预计将增长多少？**
A: 电子健康记录（EHRs）部门预计到2035年将增长至235亿美元。

**Q: 在医疗保健市场中，预计哪个应用领域将看到数据货币化的显著增长？**
A: 数据分析和洞察应用领域预计到2035年将增长至265亿美元。

**Q: 到2035年，哪个最终用户细分市场预计将主导市场？**
A: 预计到2035年，医疗服务提供者将在市场中占主导地位，估值为285亿美元。

**Q: 到2035年，预计哪种货币化模型的估值最高？**
A: 数据分析与洞察的货币化模型预计将具有最高的估值，到2035年将达到265亿美元。

**Q: 数据货币化在医疗保健市场的增长如何影响医疗保健提供者？**
A: 医疗保健市场的数据货币化增长可能增强医疗保健提供者的能力，可能使其市场估值在2035年达到285亿美元。


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/data-monetization-in-healthcare-market-28681*